Knockdown of YBX1 is suggested to be related to apoptosis induction in myeloid leukemic cells [61,62], renal cell carcinoma [63], colon cancer [64], medulloblastomas [65], glioma cells [66], prostate cancer [67], and lung adenocarcinoma [52]. Here, YBX1 is linked to medulloblastoma.